Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal remimazolam tosylate as preoperative sedation before pediatric general anesthesia
ChiCTR2000035356Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Panzhihua University
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in preoperative anxiety (3 arms), sponsored by The Affiliated Hospital of Panzhihua University. Primary endpoints: blood pressure, mean arterial pressure and 5 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2000035356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035356.